Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Advancis Pharmaceutical Corporation
Keflex powder for oral suspension launched in the United States
July 6th, 2005
Advancis Pharmaceutical Corporation (AVNC), a pharmaceutical company focused on developing and commercializing novel anti-infective products, announced that it has launched Keflex Powder for Oral Suspension (cephalexin, USP). The launch marks the return of Keflex to pharmacy shelves. Keflex Powder for Oral Suspension is available in two strengths and two bottle sizes. "We are pleased to offer Keflex to customers once again. Pediatricians and parents understand how challenging it can be to administer antibiotic therapy to pediatric patients. We are hopeful that the appealing flavor of Keflex will improve patient cooperation and compliance," stated...
Source: Biotech Week (2005-07-06)
|
